期刊文献+

表阿霉素对乳腺癌细胞系的作用效应 被引量:1

The effect of Epirubicin on breast cancer cell lines
下载PDF
导出
摘要 目的探讨表阿霉素对不同乳腺癌细胞系的作用效应。方法应用流式细胞仪检测并分析表阿霉素作用于乳腺癌细胞系MCF-7、SKBR3、MDA-MB-231及MDA-MB-468后免疫原性标志物的表达以及不同乳腺癌细胞系死亡过程中免疫原性死亡的能力;采用CCK-8方法观察表阿霉素对不同乳腺癌细胞系增殖的抑制效应。结果 (1)表阿霉素作用于各个乳腺癌细胞系24 h后,MDA-MB-231与MDA-MB-468细胞系的增殖率明显低于MCF-7细胞系的增殖率,差异有统计学意义(P<0.05)。(2)MDA-MB-231与MDA-MB-468细胞系表阿霉素作用24 h的IC50值明显低于MCF-7与SKBR3细胞系。(3)钙网蛋白、HSP70随着表阿霉素作用时间的增加而增加,24h后MDA-MB-231与MDA-MB-468细胞系中的表达明显高于MCF-7细胞系,差异有统计学意义(P<0.001)。SKBR3细胞系中钙网蛋白、HSP70的表达则稍高于MCF-7细胞系(P>0.05)。结论表阿霉素的作用效应不仅包括细胞毒性作用,还潜在免疫原性死亡作用过程;激素受体阴性乳腺癌细胞死亡过程中的免疫原性死亡作用较强。 Objective The effect of Epirubicin on different breast cancer cell lines. Methods The human breast cancer cell lines MCF7,SKBR3,MDA-MB-231 and MDA-MB-468 were treated with Epirubicin respectively,and the markers of immunogenic cell death were detected by flow cytometry; the proliferation of cell was tested by CCK-8 method. Results( 1) After treating for 24 h,the proliferation of MDA-MB-231 and MDA-MB-468 was lower than MCF-7( P〈0. 005).( 2) IC50 of Epirubicin to MDA-MB-231 and MDA-MB-468 was lower than MCF-7 and SKBR3.( 3) The amount of calreticulin and HSP70 was increased gradually with the treatment of Epirubicin; after24 hours,these markers of MDA-MB-231 and MDA-MB-468 were significantly higher than that of MCF-7( P〈0.001). The both markers of SKBR3 were higher than that of MCF-7,but not significantly( P〉0. 005). Conclusion The effect of Epirubicin not only includes cytotoxic effect,but also potential immunogenicity death process. During the process of cell death,the immunogenicity death effect of hormone receptor negative breast cancer cell is stronger.
出处 《新疆医科大学学报》 CAS 2015年第12期1520-1523,共4页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区自然科学基金(2014211C049)
关键词 表阿霉素 乳腺癌 免疫原性死亡 epirubicin breast cancer immunogenic cell death
  • 相关文献

参考文献14

  • 1Hou G, Zhang S, Zhang X, et al. Clinical pathological charac- teristics and prognostic analysis of 1,013 breast cancer patients withdiabetes[J]. Breast Cancer Res Treat, 2013, 137(3): 807-816.
  • 2Ebctc G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an o- verview of the randomised trials [J]. Lancet, 2005, 365 (9472) : 1687-1717.
  • 3Lee HH, Lim CA, Cheong YT, et al. Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancer[J]. Int J Biol Sci, 2012, 8 (3): 353-362.
  • 4Zitvogel L, Apetoh L, Ghiringhelli F, et al. The anticancer immune response: indispensable for therapeutic success? [J]. J Clin Invest, 2008, 118(6) :1991-2001.
  • 5Kepp O, Tesniere A, Schlemmer F, et al. Immunogenic cell death modalities and their impact on cancer treatment[J]. Ap- optosis, 2009, 14(4) :364-375.
  • 6Beneteau M, Zunino B, Jacquin MA, et al. Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response[J]. Proc Natl Aead Sci USA, 2012, 109(49) :20071-20076.
  • 7Calderwood SK, Mambula SS, Gray PJ, et al. Extracellular heat shock proteins in cell signaling[J]. FEBS Lett, 2007, 581 (19) :3689-3694.
  • 8Zitvogel L,Kepp O,Kroemer G. Decoding cell death signals in inflammation and immunity[J]. Cell, 2010,140(6) : 798-804.
  • 9Kepp O,Tesniere A,Zitvogel L, et al. The immunogenicity of tumor cell death[J]. Curr Opin Oncol, 2009, 21 (1) :71-76.
  • 10Brusa D,Garetto S,Chiorino G, et al. Post apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross presentation activity [J]. Vaccine, 2008, 26 (50) : 6422-6432.

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部